Answering the Call for Personnel Training in Single-Use Technologies
The need for specialized skills in biopharmaceutical manufacturing requires workforce training.
Using Modeling to Improve Data Analytics for Upstream Bioprocessing Workflows
Recent trends in data analytics highlight the use of modeling techniques to improve process control and monitoring in biopharmaceutical production.
Bio-Rad Launches Anti-Pertuzumab Antibodies
Bio-Rad’s four new antibodies will develop highly selective and sensitive assays for bioanalysis and drug monitoring of pertuzumab and its biosimilars.
Gandeeva Raises $40M to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions
Gandeeva raisded $40 million to advance its AI-driven cryo-EM platform, with which it will develop new therapeutics based on the precise imaging of protein–drug interactions.
Gene Editing Startup Metagenomi Raises $175 Million
Metagenomi has successfully raised $175 million for use toward its research pipeline.
PhoreMost Collaborates with Polaris and NeoCura on Cancer Therapeutics
PhoreMost has entered into separate collaboration agreements with Polaris Quantum Biotech and NeoCura Bio-Medical Technology to discover and develop novel cancer therapeutics.
Bristol Myers Squibb and Prellis Biologics Partner to Build Human Antibody Libraries
In their collaboration, Bristol Myers Squibb and Prellis Biologics aim to generate human antibody libraries for select targets to enable drug discovery.
Protagen Protein Services, BioAnalytix, and GeneWerk Combine to Form New CRO, ProtaGene
After a previously announced merger, Protagen Protein Services, BioAnalytix, and GeneWerk have formed a new CRO under the name ProtaGene.
Fosun Pharma and Insilico Medicine Partner on Drug Discovery and Development Using Artificial Intelligence
Fosun Pharma and Insilico Medicine will collaborate on AI-driven drug discovery and development of product candidates targeting multiple disease targets.
Bristol Myers Squibb and Century Therapeutics to Collaborate on Developing iPSC-derived Allogeneic Cell Therapies
The collaboration between Bristol Myers Squibb and Century Therapeutics will combine Century’s iPSC-derived allogeneic cell therapy platform with Bristol Myers Squibb’s expertise in cell therapy and oncology drug development.
Fujifilm Grows Lab Space at North Carolina Facility
Fujifilm Diosynth Biotechnologies' 89,000 square-foot expansion of its BioProcess Innovation Center in Research Triangle Park, N.C., will double its capacity to support process characterization.
